Health
Pfizer-BioNTech to seek Covid-19 vaccine approval in ‘days’ after successful trial
Pfizer and BioNTech said Wednesday a completed analysis of their experimental Covid-19 vaccine found it protected 95 percent of people against the ...Pfizer to start pilot delivery program for its COVID-19 vaccine in four U.S. states
Pfizer Inc <PFE.N> has launched a pilot delivery program for its experimental COVID-19 vaccine in four U.S. states, as the U.S. drugmaker ...Covid Vaccine: Moderna trial success gives world more hope in race to end pandemic
Moderna Inc’s experimental vaccine was 94.5% effective in preventing COVID-19 based on interim data from a late-stage trial, the company said on ...Hong Kong, Singapore to allow travel to each other without quarantines from November 22
A travel bubble between Hong Kong and Singapore will begin on Nov. 22, the two cities announced on Wednesday, as they moved ...Vaccine innovation sparks hope, questions
Reports that one of the vaccines for Covid-19 has shown highly promising results are a ray of hope for a world in ...Pfizer and BioNTech say their COVID-19 vaccine is over 90% effective
Pfizer Inc said on Monday its experimental COVID-19 vaccine was more than 90% effective, a major victory in the fight against a ...President-elect Joe Biden vows immediate, science-based action on virus
President-elect Joe Biden vowed Saturday immediate action to contain the United States’ coronavirus crisis, signalling science would dominate the national response once ...Britain prepares for COVID-19 vaccine as Oxford forecasts result this year
Late-stage trial results of a potential COVID-19 vaccine being developed by the University of Oxford and AstraZeneca could be presented this year ...Germany readies exhibition halls, mobile teams for COVID-19 vaccination
Germany is scouting trade fair halls and airport terminals to use as potential mass vaccination centres, as it draws up plans to ...Putin says equipment a problem in production of Russian COVID-19 vaccines
President Vladimir Putin said on Thursday that Russia was facing challenges scaling up production of its main COVID-19 vaccine due to problems ...














